Genetics of recessive cognitive disorders

Trends in Genetics

Volumn 30, Issue 1, 2014, Pages 32-39

  Musante, Luciana ^a   Ropers, H Hilger ^a  

^a MAX PLANCK INSTITUTE FOR MOLECULAR GENETICS   (Germany)

Author keywords

Autosomal recessive ID; Healthcare; Homozygosity mapping; Next generation sequencing

Indexed keywords

MEMBRANE PROTEIN; RAB PROTEIN;

ADRENOLEUKODYSTROPHY; AUTISM; AUTOSOMAL RECESSIVE DISORDER; COMPARATIVE GENOMIC HYBRIDIZATION; CONSANGUINEOUS MARRIAGE; DISEASE ASSOCIATION; EPILEPSY; FRAGILE X SYNDROME; GENE IDENTIFICATION; GENE MAPPING; GENE SEQUENCE; GENE TARGETING; GENETIC RISK; GENETICS; HOMOZYGOSITY; HUMAN; ICD-10; INTELLECTUAL IMPAIRMENT; PRIORITY JOURNAL; RECURRENCE RISK; RETT SYNDROME; REVIEW; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TUBEROUS SCLEROSIS; X CHROMOSOME; ZELLWEGER SYNDROME;

AUTOSOMAL RECESSIVE ID; HEALTHCARE; HOMOZYGOSITY MAPPING; NEXT-GENERATION SEQUENCING;

COGNITION DISORDERS; CONSANGUINITY; GENES, RECESSIVE; GENES, X-LINKED; GENETIC LINKAGE; GENETIC LOCI; HUMANS; INTELLECTUAL DISABILITY; MUTATION;

EID: 84891157201     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tig.2013.09.008     Document Type: Review

References (109)

1. Schalock R.L., et al. The renaming of mental retardation: understanding the change to the term intellectual disability. Intellect. Dev. Disabil. 2007, 45:116-124.
2. American Psychiatric Association Diagnostic and Statistic Manual of Mental Disorders 2000, American Psychiatric Association. 4th Revision: DSM-IV-TR.
3. Leonard H., Wen X. The epidemiology of mental retardation: challenges and opportunities in the new millennium. Ment. Retard. Dev. Disabil. Res. Rev. 2002, 8:117-134.
4. Ropers H.H. Genetics of early onset cognitive impairment. Annu. Rev. Genomics Hum. Genet. 2010, 11:161-187.
5. Kleefstra T., Hamel B.C. X-linked mental retardation: further lumping, splitting and emerging phenotypes. Clin. Genet. 2005, 67:451-467.
6. Lubs H.A., et al. Fragile X and X-linked intellectual disability: four decades of discovery. Am. J. Hum. Genet. 2012, 90:579-590.
7. Piton A., et al. XLID-causing mutations and associated genes challenged in light of data form large-scale human exome sequencing. Am. J. Hum. Genet. 2013, 93:368-383.
8. Mefford H.C., et al. Genomics, intellectual disability, and autism. N. Engl. J. Med. 2012, 366:733-743.
9. Veltman J.A., Brunner H.G. De novo mutations in human genetic disease. Nat. Rev. Genet. 2012, 13:565-575.
10. Rauch A., et al. Diagnostic yield of various genetic approaches in patients with unexplained developmental delay or mental retardation. Am. J. Med. Genet. A 2006, 140:2063-2074.
11. de Ligt J., et al. Diagnostic exome sequencing in persons with severe intellectual disability. N. Engl. J. Med. 2012, 367:1921-1929.
12. Lander E.S., Botstein D. Homozygosity mapping: a way to map human recessive traits with the DNA of inbred children. Science 1987, 236:1567-1570.
13. Najmabadi H., et al. Homozygosity mapping in consanguineous families reveals extreme heterogeneity of non-syndromic autosomal recessive mental retardation and identifies 8 novel gene loci. Hum. Genet. 2007, 121:43-48.
14. Kuss A.W., et al. Autosomal recessive mental retardation: homozygosity mapping identifies 27 single linkage intervals, at least 14 novel loci and several mutation hotspots. Hum. Genet. 2011, 129:141-148.
15. Abou Jamra R., et al. Homozygosity mapping in 64 Syrian consanguineous families with non-specific intellectual disability reveals 11 novel loci and high heterogeneity. Eur. J. Hum. Genet. 2011, 19:1161-1166.
16. Duman D., Tekin M. Autosomal recessive nonsyndromic deafness genes: a review. Front. Biosci. 2012, 17:2213-2236.
17. Pak C., et al. Mutation of the conserved polyadenosine RNA binding protein, ZC3H14/dNab2, impairs neural function in Drosophila and humans. Proc. Natl. Acad. Sci. U.S.A. 2011, 108:12390-12395.
18. Hashimoto S., et al. MED23 mutation links intellectual disability to dysregulation of immediate early gene expression. Science 2011, 333:1161-1163.
19. Caliskan M., et al. Exome sequencing reveals a novel mutation for autosomal recessive non-syndromic mental retardation in the TECR gene on chromosome 19p13. Hum. Mol. Genet. 2011, 20:1285-1289.
20. Chong J.X., et al. A population-based study of autosomal-recessive disease-causing mutations in a founder population. Am. J. Hum. Genet. 2012, 91:608-620.
21. Meloni I., et al. FACL4, encoding fatty acid-CoA ligase 4, is mutated in nonspecific X-linked mental retardation. Nat. Genet. 2002, 30:436-440.
22. Najmabadi H., et al. Deep sequencing reveals 50 novel genes for recessive cognitive disorders. Nature 2011, 478:57-63.
23. Schuurs-Hoeijmakers J.H.M. Gene Identification in Intellectual Disability 2012, Radboud University Nijmegen.
24. Schuurs-Hoeijmakers J.H., et al. Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia. Am. J. Hum. Genet. 2012, 91:1073-1081.
25. Markert A., et al. The La-related protein LARP7 is a component of the 7SK ribonucleoprotein and affects transcription of cellular and viral polymerase II genes. EMBO Rep. 2008, 9:569-575.
26. Alazami A.M., et al. Loss of function mutation in LARP7, chaperone of 7SK ncRNA, causes a syndrome of facial dysmorphism, intellectual disability, and primordial dwarfism. Hum. Mutat. 2012, 33:1429-1434.
27. Zamponi G.W., et al. Role of voltage-gated calcium channels in epilepsy. Pflugers Arch. 2010, 460:395-403.
28. Al-Owain M., et al. An autosomal recessive syndrome of severe cognitive impairment, dysmorphic facies and skeletal abnormalities maps to the long arm of chromosome 17. Clin. Genet. 2011, 80:489-492.
29. Preiksaitiene E., et al. A novel de novo 1.8Mb microdeletion of 17q21.33 associated with intellectual disability and dysmorphic features. Eur. J. Med. Genet. 2012, 55:656-659.
30. Abbasi-Moheb L., et al. Mutations in NSUN2 cause autosomal-recessive intellectual disability. Am. J. Hum. Genet. 2012, 90:847-855.
31. Khan M.A., et al. Mutation in NSUN2, which encodes an RNA methyltransferase, causes autosomal-recessive intellectual disability. Am. J. Hum. Genet. 2012, 90:856-863.
32. Martinez F.J., et al. Whole exome sequencing identifies a splicing mutation in NSUN2 as a cause of a Dubowitz-like syndrome. J. Med. Genet. 2012, 49:380-385.
33. Brzezicha B., et al. Identification of human tRNA:m5C methyltransferase catalysing intron-dependent m5C formation in the first position of the anticodon of the pre-tRNA Leu (CAA). Nucleic Acids Res. 2006, 34:6034-6043.
34. Freude K., et al. Mutations in the FTSJ1 gene coding for a novel S-adenosylmethionine-binding protein cause nonsyndromic X-linked mental retardation. Am. J. Hum. Genet. 2004, 75:305-309.
35. Bardoni B., et al. Intellectual disabilities, neuronal posttranscriptional RNA metabolism, and RNA-binding proteins: three actors for a complex scenario. Prog. Brain Res. 2012, 197:29-51.
36. Noor A., et al. CC2D2A, encoding a coiled-coil and C2 domain protein, causes autosomal-recessive mental retardation with retinitis pigmentosa. Am. J. Hum. Genet. 2008, 82:1011-1018.
37. Khan M.A., et al. A novel deletion mutation in the TUSC3 gene in a consanguineous Pakistani family with autosomal recessive nonsyndromic intellectual disability. BMC Med. Genet. 2011, 12:56.
38. Loddo S., et al. Homozygous deletion in TUSC3 causing syndromic intellectual disability: a new patient. Am. J. Med. Genet. A 2013, 161:2084-2087.
39. Hu H., et al. ST3GAL3 mutations impair the development of higher cognitive functions. Am. J. Hum. Genet. 2011, 89:407-414.
40. Marangi G., et al. TRAPPC9-related autosomal recessive intellectual disability: report of a new mutation and clinical phenotype. Eur. J. Hum. Genet. 2013, 21:229-232.
41. Rafiq M.A., et al. Mutations in the alpha 1,2-mannosidase gene, MAN1B1, cause autosomal-recessive intellectual disability. Am. J. Hum. Genet. 2011, 89:176-182.
42. Winkler G.S., et al. RNA polymerase II elongator holoenzyme is composed of two discrete subcomplexes. J. Biol. Chem. 2001, 276:32743-32749.
43. Puffenberger E.G., et al. Genetic mapping and exome sequencing identify variants associated with five novel diseases. PLoS ONE 2012, 7:e28936.
44. Ribe E.M., et al. Neuronal caspase 2 activity and function requires RAIDD, but not PIDD. Biochem. J. 2012, 444:591-599.
45. Bjursell M.K., et al. Adenosine kinase deficiency disrupts the methionine cycle and causes hypermethioninemia, encephalopathy, and abnormal liver function. Am. J. Hum. Genet. 2011, 89:507-515.
46. Ali B.R., et al. A mutation in KIF7 is responsible for the autosomal recessive syndrome of macrocephaly, multiple epiphyseal dysplasia and distinctive facial appearance. Orphanet J. Rare Dis. 2012, 7:27.
47. Eggert S.L., et al. Genome-wide linkage and association analyses implicate FASN in predisposition to uterine leiomyomata. Am. J. Hum. Genet. 2012, 91:621-628.
48. Frayling T.M., et al. A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007, 316:889-894.
49. Boissel S., et al. Loss-of-function mutation in the dioxygenase-encoding FTO gene causes severe growth retardation and multiple malformations. Am. J. Hum. Genet. 2009, 85:106-111.
50. Oeseburg B., et al. Prevalence of chronic health conditions in children with intellectual disability: a systematic literature review. Intellect. Dev. Disabil. 2011, 49:59-85.
51. Berg A.T., Plioplys S. Epilepsy and autism: is there a special relationshipα. Epilepsy Behav. 2012, 23:193-198.
52. Prince E., Ring H. Causes of learning disability and epilepsy: a review. Curr. Opin. Neurol. 2011, 24:154-158.
53. Stevenson R.E., et al. Seizures and X-linked intellectual disability. Eur. J. Med. Genet. 2012, 55:307-312.
54. Leung H.T., Ring H. Epilepsy in four genetically determined syndromes of intellectual disability. J. Intellect. Disabil. Res. 2013, 57:3-20.
55. Corbett M.A., et al. A focal epilepsy and intellectual disability syndrome is due to a mutation in TBC1D24. Am. J. Hum. Genet. 2010, 87:371-375.
56. Falace A., et al. TBC1D24, an ARF6-interacting protein, is mutated in familial infantile myoclonic epilepsy. Am. J. Hum. Genet. 2010, 87:365-370.
57. Guven A., Tolun A. TBC1D24 truncating mutation resulting in severe neurodegeneration. J. Med. Genet. 2013, 50:199-202.
58. Milh M., et al. Novel compound heterozygous mutations in TBC1D24 cause familial malignant migrating partial seizures of infancy. Hum. Mutat. 2013, 34:869-872.
59. Labate A., et al. Homozygous c.649dupC mutation in PRRT2 worsens the BFIS/PKD phenotype with mental retardation, episodic ataxia, and absences. Epilepsia 2012, 53:e196-e199.
60. Helbig I., Lowenstein D.H. Genetics of the epilepsies: where are we and where are we goingα. Curr. Opin. Neurol. 2013, 26:179-185.
61. Fombonne E. Epidemiological surveys of autism and other pervasive developmental disorders: an update. J. Autism Dev. Disord. 2003, 33:365-382.
62. Jamain S., et al. Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat. Genet. 2003, 34:27-29.
63. Laumonnier F., et al. X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am. J. Hum. Genet. 2004, 74:552-557.
64. Celestino-Soper P.B., et al. A common X-linked inborn error of carnitine biosynthesis may be a risk factor for nondysmorphic autism. Proc. Natl. Acad. Sci. U.S.A. 2012, 109:7974-7981.
65. Jiang Y.H., et al. Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing. Am. J. Hum. Genet. 2013, 93:249-263.
66. Morgan V.A., et al. Intellectual disability co-occurring with schizophrenia and other psychiatric illness: population-based study. Br. J. Psychiatry 2008, 193:364-372.
67. Kirov G., et al. Support for the involvement of large copy number variants in the pathogenesis of schizophrenia. Hum. Mol. Genet. 2009, 18:1497-1503.
68. de Kovel C.G., et al. Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. Brain 2010, 133:23-32.
69. Betancur C. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting. Brain Res. 2011, 1380:42-77.
70. Guven A., et al. Novel NDE1 homozygous mutation resulting in microhydranencephaly and not microlyssencephaly. Neurogenetics 2012, 13:189-194.
71. Iossifov I., et al. De novo gene disruptions in children on the autistic spectrum. Neuron 2012, 74:285-299.
72. Ullmann R., et al. Array CGH identifies reciprocal 16p13.1 duplications and deletions that predispose to autism and/or mental retardation. Hum. Mutat. 2007, 28:674-682.
73. Nicolson R., Szatmari P. Genetic and neurodevelopmental influences in autistic disorder. Can. J. Psychiatry 2003, 48:526-537.
74. Sanders S.J., et al. De novo mutations revealed by whole-exome sequencing are strongly associated with autism. Nature 2012, 485:237-241.
75. O'Roak B.J., et al. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations. Nature 2012, 485:246-250.
76. Neale B.M., et al. Patterns and rates of exonic de novo mutations in autism spectrum disorders. Nature 2012, 485:242-245.
77. Morrow E.M., et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 2008, 321:218-223.
78. Gamsiz E.D., et al. Intellectual disability is associated with increased runs of homozygosity in simplex autism. Am. J. Hum. Genet. 2013, 93:103-109.
79. Yu T.W., et al. Using whole-exome sequencing to identify inherited causes of autism. Neuron 2013, 77:259-273.
80. Chahrour M.H., et al. Whole-exome sequencing and homozygosity analysis implicate depolarization-regulated neuronal genes in autism. PLoS Genet. 2012, 8:e1002635.
81. Lim E.T., et al. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders. Neuron 2013, 77:235-242.
82. Mansour H.A., et al. Association study of 21 circadian genes with bipolar I disorder, schizoaffective disorder, and schizophrenia. Bipolar Disord. 2009, 11:701-710.
83. Mansour H., et al. Consanguinity and increased risk for schizophrenia in Egypt. Schizophr. Res. 2010, 120:108-112.
84. Dratva J., et al. Variability of reproductive history across the Swiss SAPALDIA cohort - patterns and main determinants. Ann. Hum. Biol. 2007, 34:437-453.
85. Ten Kate L.P., et al. Autosomal recessive disease in children of consanguineous parents: inferences from the proportion of compound heterozygotes. J. Community Genet. 2010, 1:37-40.
86. Rauch A., et al. Range of genetic mutations associated with severe non-syndromic sporadic intellectual disability: an exome sequencing study. Lancet 2012, 380:1674-1682.
87. Ellison J.W., et al. Genetic basis of intellectual disability. Annu. Rev. Med. 2013, 64:441-450.
88. Hoodfar E., Teebi A.S. Genetic referrals of Middle Eastern origin in a western city: inbreeding and disease profile. J. Med. Genet. 1996, 33:212-215.
89. Hamamy H.A., et al. Consanguinity and genetic disorders. Profile from Jordan. Saudi Med. J. 2007, 28:1015-1017.
90. Zoghbi H.Y., Warren S.T. Neurogenetics: advancing the 'next-generation' of brain research. Neuron 2010, 68:165-173.
91. Lynch M. Rate, molecular spectrum, and consequences of human mutation. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:961-968.
92. Vissers L.E., et al. A de novo paradigm for mental retardation. Nat. Genet. 2010, 42:1109-1112.
93. Dixon-Salazar T.J., et al. Exome sequencing can improve diagnosis and alter patient management. Sci. Transl. Med. 2012, 4:138ra178.
94. Bell C.J., et al. Carrier testing for severe childhood recessive diseases by next-generation sequencing. Sci. Transl. Med. 2011, 3:65ra64.
95. Kingsmore S. Comprehensive carrier screening and molecular diagnostic testing for recessive childhood diseases. PLoS Curr. 2012, 1:1-23. [Edition1]. 10.1371/e4f9877ab8ffa9.
96. Bittles A.H. A community genetics perspective on consanguineous marriage. Community Genet. 2008, 11:324-330.
97. Modell B., Darr A. Science and society: genetic counselling and customary consanguineous marriage. Nat. Rev. Genet. 2002, 3:225-229.
98. Wright S. Coefficients of inbreeding and relationship. Am. Nat. 1922, 56:330-338.
99. Molinari F., et al. Truncating neurotrypsin mutation in autosomal recessive nonsyndromic mental retardation. Science 2002, 298:1779-1781.
100. Higgins J.J., et al. A mutation in a novel ATP-dependent Lon protease gene in a kindred with mild mental retardation. Neurology 2004, 63:1927-1931.
101. Basel-Vanagaite L., et al. The CC2D1A, a member of a new gene family with C2 domains, is involved in autosomal recessive non-syndromic mental retardation. J. Med. Genet. 2006, 43:203-210.
102. Motazacker M.M., et al. A defect in the ionotropic glutamate receptor 6 gene (GRIK2) is associated with autosomal recessive mental retardation. Am. J. Hum. Genet. 2007, 81:792-798.
103. Garshasbi M., et al. A defect in the TUSC3 gene is associated with autosomal recessive mental retardation. Am. J. Hum. Genet. 2008, 82:1158-1164.
104. Molinari F., et al. Oligosaccharyltransferase-subunit mutations in nonsyndromic mental retardation. Am. J. Hum. Genet. 2008, 82:1150-1157.
105. Mir A., et al. Identification of mutations in TRAPPC9, which encodes the NIK- and IKK-beta-binding protein, in nonsyndromic autosomal-recessive mental retardation. Am. J. Hum. Genet. 2009, 85:909-915.
106. Philippe O., et al. Combination of linkage mapping and microarray-expression analysis identifies NF-kappaB signaling defect as a cause of autosomal-recessive mental retardation. Am. J. Hum. Genet. 2009, 85:903-908.
107. Mochida G.H., et al. A truncating mutation of TRAPPC9 is associated with autosomal-recessive intellectual disability and postnatal microcephaly. Am. J. Hum. Genet. 2009, 85:897-902.
108. Ratan A., et al. Comparison of sequencing platforms for single nucleotide variant calls in a human sample. PLoS ONE 2013, 8:e55089.
109. Ropers F., et al. Identification of a novel candidate gene for non-syndromic autosomal recessive intellectual disability: the WASH complex member SWIP. Hum. Mol. Genet. 2011, 20:2585-2590.